Newborns with hypoplastic left heart syndrome (HLHS) who are considered at increased risk for death following Norwood/Sano surgery often undergo hybrid palliation (HP) as initial surgery. We aimed to compile the HP experience in HLHS and its variants and assess the rates of, and risk factors for, death and heart transplantation.
Methods
CINAHL, CINAHL PLUS, PubMed/MEDLINE, and SCOPUS were systematically searched for HP outcome studies of death or heart transplantation in HLHS between 1998 and 2022. Pooled incidence was estimated, and potential risk factors were identified using random-effects meta-analysis and reconstructed time-to-event data from Kaplan-Meier curves.
Results
Thirty-three publications were included in our review. Overall, of 1,162 patients 417 died and 57 underwent heart transplantation, resulting in a combined outcome of 40.7%, (474/1,162). There was a trend toward decreasing mortality risk across the stages of palliation. Pooled mortality between HP and comprehensive stage 2 palliation was 25%, after stage 2 up to Fontan palliation was 16%, and 6% post-Fontan. The incidence of death or heart transplantation was higher in high-risk patients—43% died and 10% received heart transplantation.
Conclusion
Our systematic review and meta-analysis found high rates of death or heart transplantation in HP of HLHS patients between HP and Fontan surgeries. All patients should be closely followed during the initial interstage period, which is associated with the highest hazard. Prospective studies on appropriate patient selection, indications, and / or alternatives, as well as refining HP strategies for managing newborns with HLHS are needed to improve outcomes.
GibbsJLWrenCWattersonKGHunterSHamiltonJR. Stenting of the arterial duct combined with banding of the pulmonary arteries and atrial septectomy or septostomy: a new approach to palliation for the hypoplastic left heart syndrome. Br Heart J. 1993;69(6):551-555. doi:10.1136/hrt.69.6.551
2.
GibbsJLUzunOBlackburnMECWrenCHamiltonJRLWattersonKG. Fate of the stented arterial duct. Circulation. 1999;99(20):2621-2625. doi:10.1161/01.CIR.99.20.2621
3.
Michel-BehnkeIAkintürkHSchranzD. Fate of the stented arterial duct. Circulation. 2000;102(22):e178-e178. doi:10.1161/01.CIR.102.22.e178
4.
AkintuerkHMichel-BehnkeIValeskeK, et al.Stenting of the arterial duct and banding of the pulmonary arteries: basis for combined Norwood stage I and II repair in hypoplastic left heart. Circulation. 2002;105(9):1099-1103. doi:10.1161/hc0902.104709
5.
GalantowiczMCheathamJPPhillipsA, et al.Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg. 2008;85(6):2061-2063. doi:10.1016/j.athoracsur.2008.02.009
6.
BachaEADavesSHardinJ, et al.Single-ventricle palliation for high-risk neonates: the emergence of an alternative hybrid stage I strategy. J Thorac Cardiovasc Surg. 2006;131(1):163-171.e2. doi:10.1016/j.jtcvs.2005.07.053
7.
MitchellMBCampbellDNBoucekMM, et al.Mechanical limitation of pulmonary blood flow facilitates heart transplantation in older infants with hypoplastic left heart syndrome. Eur J Cardiothorac Surg.2003;23(5):735-742. doi:10.1016/s1010-7940(03)00106-4
8.
GaynorJWMahleWTCohenMI, et al.Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg.2002;22(1):82-89. doi:10.1016/s1010-7940(02)00198-7
9.
SimsicJMBradleySMStroudMRAtzAM. Risk factors for interstage death after the Norwood procedure. Pediatr Cardiol. 2005;26(4):400-403. doi:10.1007/s00246-004-0776-4
10.
GlatzJAFedderlyRTGhanayemNSTweddellJS. Impact of mitral stenosis and aortic atresia on survival in hypoplastic left heart syndrome. Ann Thorac Surg. 2008;85(6):2057-2062. doi:10.1016/j.athoracsur.2008.02.026
11.
KulkarniANeugebauerRLoY, et al.Outcomes and risk factors for listing for heart transplantation after the Norwood procedure: an analysis of the single ventricle reconstruction trial. J Heart Lung Transplant.2016;35(3):306-311. doi:10.1016/j.healun.2015.10.033
12.
GelehrterSFiferCGArmstrongAHirschJGajarskiR. Outcomes of hypoplastic left heart syndrome in low-birth-weight patients. Pediatr Cardiol. 2011;32(8):1175-1181. doi:10.1007/s00246-011-0053-2
13.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ.2021;372:n71. doi:10.1136/bmj.n71
14.
SterneJACHernánMAReevesBC, et al.ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ.2016;355, i4919. doi:10.1136/bmj.i4919
15.
WeiYRoystonP. Reconstructing time-to-event data from published Kaplan-Meier curves. Stata J. 2017;17(4):786-802.
16.
LiuNZhouYLeeJJ. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2021;21(1):111. doi:10.1186/s12874-021-01308-8
17.
HigginsJPTThompsonSGDeeksJJAltmanDG. Measuring inconsistency in meta-analyses. Br Med J.2003;327(7414):557-560. doi:10.1136/bmj.327.7414.557
18.
BeggCBMazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-1101.
19.
EggerMSmithGDSchneiderMMinderC. Bias in meta-analysis detected by a simple, graphical test. Br Med J.1997;315(7109):629634. doi:10.1136/bmj.315.7109.629
20.
ChetanDKotaniYJacquesF, et al.Surgical palliation strategy does not affect interstage ventricular dysfunction or atrioventricular valve regurgitation in children with hypoplastic left heart syndrome and variants. Circulation. 2013;128(11 suppl 1):S205-S212. doi:10.1161/CIRCULATIONAHA.112.000380
21.
DaviesRRRadtkeWBhatMABaffaJMWoodfordEPizarroC. Hybrid palliation for critical systemic outflow obstruction: neither rapid stage 1 Norwood nor comprehensive stage 2 mitigate consequences of early risk factors. J Thorac Cardiovasc Surg. 2015;149(1):182-193. doi:10.1016/j.jtcvs.2014.09.030
22.
DiBardinoDJGomez-ArosteguiJKempA, et al.Intermediate results of hybrid versus primary Norwood operation. Ann Thorac Surg. 2015;99(6):2141-2149. doi:10.1016/j.athoracsur.2015.02.025
23.
GalantowiczMYatesAR. Improved outcomes with the comprehensive stage 2 procedure after an initial hybrid stage 1. J Thorac Cardiovasc Surg. 2016;151(2):424-429. doi:10.1016/j.jtcvs.2015.10.023
24.
GomideMFurciBMimicB, et al.Rapid 2-stage Norwood I for high-risk hypoplastic left heart syndrome and variants. J Thorac Cardiovasc Surg. 2013;146(5):1142-1146. doi:10.1016/j.jtcvs.2013.01.051
25.
KaramlouTOvermanDHillKD, et al.Stage 1 hybrid palliation for hypoplastic left heart syndrome–assessment of contemporary patterns of use: an analysis of the society of thoracic surgeons congenital heart surgery database. J Thorac Cardiovasc Surg. 2015;149(1):195-202.e1. doi:10.1016/j.jtcvs.2014.08.020
26.
LatusHNassarMSWongJ, et al.Ventricular function and vascular dimensions after Norwood and hybrid palliation of hypoplastic left heart syndrome. Heart. 2018;104(3):244-252. doi:10.1136/heartjnl-2017-311532
27.
LimDSPeelerBBMatherneGPKronILGutgesellHP. Risk-stratified approach to hybrid transcatheter-surgical palliation of hypoplastic left heart syndrome. Pediatr Cardiol. 2006;27(1):91-95. doi:10.1007/s00246-005-1028-y
28.
LloydDFACutlerLTibbySM, et al.Analysis of preoperative condition and interstage mortality in Norwood and hybrid procedures for hypoplastic left heart syndrome using the Aristotle scoring system. Heart. 2014;100(10):775-780. doi:10.1136/heartjnl-2013-304759
29.
MorrayBHAlbersELJonesTKKemnaMSPermutLCLawYM. Hybrid stage 1 palliation as a bridge to cardiac transplantation in patients with high-risk single ventricle physiology. Pediatr Transplant. 2018;22(8):e13307. doi:10.1111/petr.13307
30.
MurphyMOBellsham-RevellHMorganGJ, et al.Hybrid procedure for neonates with hypoplastic left heart syndrome at high-risk for Norwood: midterm outcomes. Ann Thorac Surg. 2015;100(6):2282-2286. doi:10.1016/j.athoracsur.2015.06.098
31.
PillaCBPedraCACNogueiraAJS, et al.Hybrid management for hypoplastic left heart syndrome: an experience from Brazil. Pediatr Cardiol. 2008;29(3):498-506. doi:10.1007/s00246-007-9136-5
32.
PizarroCDaviesRRWoodfordERadtkeWA. Improving early outcomes following hybrid procedure for patients with single ventricle and systemic outflow obstruction: defining risk factors†. Eur J Cardiothorac Surg.2015;47(6):995-1001. doi:10.1093/ejcts/ezu373
33.
RoeleveldPPWildeRdHazekampMRycusPTThiagarajanRR. Extracorporeal membrane oxygenation in single ventricle lesions palliated via the hybrid approach. World J Pediatr Congenit Heart Surg. 2014;5(3):393-397. doi:10.1177/2150135114526420
34.
SakuraiTKadoHNakanoT, et al.Early results of bilateral pulmonary artery banding for hypoplastic left heart syndrome. Eur J Cardiothorac Surg.2009;36(6):973-979. doi:10.1016/j.ejcts.2009.05.009
35.
SasakiTTakahashiYAndoMWadaNKawaseYSekiH. Bilateral pulmonary artery banding for hypoplastic left heart syndrome and related anomalies. Gen Thorac Cardiovasc Surg. 2008;56(4):158-162. doi:10.1007/s11748-007-0207-6
36.
SchranzDBauerAReichB, et al.Fifteen-year single center experience with the “Giessen Hybrid” approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol. 2015;36(2):365-373. doi:10.1007/s00246-014-1015-2
37.
SowerCTRomanoJCYuSLoweryRPasqualiSKZampiJD. Early and midterm outcomes in high-risk single-ventricle patients: hybrid vs Norwood palliation. Ann Thorac Surg. 2019;108(6):1849-1855. doi:10.1016/j.athoracsur.2019.06.061
38.
StoicaSCPhilipsABEganM, et al.The retrograde aortic arch in the hybrid approach to hypoplastic left heart syndrome. Ann Thorac Surg. 2009;88(6):1937-1939. doi:10.1016/j.athoracsur.2009.06.115
39.
VenugopalPSLunaKPAndersonDR, et al.Hybrid procedure as an alternative to surgical palliation of high-risk infants with hypoplastic left heart syndrome and its variants. J Thorac Cardiovasc Surg. 2010;139(5):1211-1215. doi:10.1016/j.jtcvs.2009.11.037
40.
AkintürkHYörükerUSchranzD. Hypoplastic left heart syndrome palliation: technical aspects and common pitfalls of the hybrid approach. World J Pediatr Congenit Heart Surg. 2022;13(5):588-592. doi:10.1177/21501351221099935
41.
WilderTJMcCrindleBWHickeyEJ, et al.Is a hybrid strategy a lower-risk alternative to stage 1 Norwood operation?J Thorac Cardiovasc Surg. 2017;153(1):163-172. e6. doi:10.1016/j.jtcvs.2016.08.021
42.
YerebakanCValeskeKElmontaserH, et al.Hybrid therapy for hypoplastic left heart syndrome: myth, alternative, or standard?J Thorac Cardiovasc Surg. 2016;151(4):1112-1123.e5. doi:10.1016/j.jtcvs.2015.10.066
43.
ArtripJHCampbellDNIvyDD, et al.Birth weight and complexity are significant factors for the management of hypoplastic left heart syndrome. Ann Thorac Surg. 2006;82(4):1252-1259. doi:10.1016/j.athoracsur.2006.04.062
44.
BabaKKotaniYChetanD, et al.Hybrid versus Norwood strategies for single-ventricle palliation. Circulation. 2012;126(11 suppl 1):S123-S131. doi:10.1161/CIRCULATIONAHA.111.084616
45.
BoucekMMMashburnCChanKC. Catheter-based interventional palliation for hypoplastic left heart syndrome. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005:72-77. doi:10.1053/j.pcsu.2005.01.009
46.
CaldaroneCABensonLHoltbyHLiJRedingtonANVan ArsdellGS. Initial experience with hybrid palliation for neonates with single-ventricle physiology. Ann Thorac Surg. 2007;84(4):1294-1300. doi:10.1016/j.athoracsur.2007.04.127
47.
CarrilloSATexterKMPhelpsCTanYMcConnellPIGalantowiczM. Tricuspid valve and right ventricular function throughout the hybrid palliation strategy for hypoplastic left heart syndrome and variants. World J Pediatr Congenit Heart Surg. 2021;12(1):9-16. doi:10.1177/2150135120947692
48.
CeneriNMDesaiMHTongutA, et al.Hybrid strategy in neonates with ductal-dependent systemic circulation and multiple risk factors. J Thorac Cardiovasc Surg. 2022;164(5):1291-1303.e6. doi:10.1016/j.jtcvs.2021.11.103
49.
BakerCECorsiniCCosentinoD, et al.Effects of pulmonary artery banding and retrograde aortic arch obstruction on the hybrid palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2013;146(6):1341-1348. doi:10.1016/j.jtcvs.2013.01.038
50.
NwankwoUTMorellEMTruccoSMMorellVOKreutzerJ. Hybrid strategy for neonates with ductal-dependent systemic circulation at high risk for Norwood. Ann Thorac Surg. 2018;106(2):595-601. doi:10.1016/j.athoracsur.2018.03.007
51.
NewburgerJWSleeperLAGaynorJW, et al.Transplant-Free survival and interventions at 6 years in the SVR trial. Circulation. 2018;137(21):2246-2253. doi:10.1161/CIRCULATIONAHA.117.029375
52.
TanemJRuddNRauscherJScottAFrommeltMAHillGD. Survival after Norwood procedure in high-risk patients. Ann Thorac Surg. 2020;109(3):828-833. doi:10.1016/j.athoracsur.2019.07.070
53.
RahkonenOChaturvediRRBensonLHonjoOCaldaroneCALeeKJ. Pulmonary artery stenosis in hybrid single-ventricle palliation: high incidence of left pulmonary artery intervention. J Thorac Cardiovasc Surg. 2015;149(4):1102-1110. e2. doi:10.1016/j.jtcvs.2014.11.080
54.
WilderTJCaldaroneCA. Apples to oranges: making sense of hybrid palliation for hypoplastic left heart syndrome. JTCVS Open. 2020;4:47-54. doi:10.1016/j.xjon.2020.10.002
55.
DiBardinoDJ. Long-term progression and survival following Norwood single ventricle reconstruction. Curr Opin Cardiol. 2015;30(1):95-99. doi:10.1097/HCO.0000000000000129
56.
StasikCNGelehrterSGoldbergCSBoveELDevaneyEJOhyeRG. Current outcomes and risk factors for the Norwood procedure. J Thorac Cardiovasc Surg. 2006;131(2):412-417. doi:10.1016/j.jtcvs.2005.09.030
57.
BackesERAfonsoNSGuffeyD, et al.Cumulative comorbid conditions influence mortality risk after staged palliation for hypoplastic left heart syndrome and variants. J Thorac Cardiovasc Surg. 2023;165(1):287-298.e4. doi:10.1016/j.jtcvs.2022.01.056
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
